About Alpa Laboratories Limited
Data last updated: 06 January 2026
Alpa Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 March 1988, the company has been in operation for over 38 years.
Registered with ROC Gwalior under CIN U85195MP1988PLC004446. Listed on BSE: 532878 and NSE: BE : ALPA.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹21.04 Cr. Formerly known as Alpa Laboratories Private Limited. It is led by directors including Mahendra Singh Chawla and Pravin Chandra Shah.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹105.81 Cr, a decline of 5.91% compared to the previous year. The net worth stands at ₹186.28 Cr (up 8.66% YoY). Total assets are valued at ₹242.14 Cr (up 8.78% YoY).
The company has a workforce of approximately 367 employees as per the latest available data.
The company is associated with 2 brands - Alpa Labs, Alpa Labs. As per MCA filings, the company has open charges of ₹26 Cr and satisfied charges of ₹81.73 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alpalabs.in.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered Address33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Alpa Laboratories Limited
Alpa Laboratories Limited has one previous CIN (Corporate Identification Number): U85195MP1988PLC004446. The current CIN is L85195MP1988PLC004446, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85195MP1988PLC004446 | Current |
| U85195MP1988PLC004446 | Previous |
Associated Brands with Alpa Laboratories Limited
Alpa Laboratories Limited operates two associated brands: Alpa Labs and Alpa Labs. These brands represent Alpa Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic drugs manufacturer & exporter | alpalabs.com | |
| Alpa Labs is engaged in manufacturing pharmaceutical dosage forms. | alpalabs.in |
Business Activity of Alpa Laboratories Limited
Alpa Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Alpa Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Alpa Laboratories Limited
Alpa Laboratories Limited is audited by CH Padliya and Co. (ICAI peer reviewed, certificate valid till 2026-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| CH Padliya and Co. (ICAI peer reviewed, certificate valid till 2026-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors and KMP of Alpa Laboratories Limited
Alpa Laboratories Limited currently reports 10 directors and 1 key managerial person. 15 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bakulesh Shah | Cfo | 29 May 2014 | 12 Years 1 Months | Current |
|
Mahendra Singh Chawla
Also directs:
Norfolk Mercantile Private Limited
|
Whole-Time Director | 18 Mar 1988 | 38 Years 3 Months | Current |
|
Pravin Chandra Shah
Also directs:
Norfolk Mercantile Private Limited
|
Whole-Time Director | 01 Mar 2009 | 17 Years 4 Months | Current |
| Paresh Chawla | Managing Director | 28 May 2016 | 10 Years 1 Months | Current |
| Jyoti Jain | Director | 20 Jul 2016 | 9 Years 11 Months | Current |
| Vitthal Kothana | Director | 13 Aug 2022 | 3 Years 11 Months | Current |
Financials of Alpa Laboratories Limited FY 2026 filings available
Alpa Laboratories Limited reported revenue of ₹105.81 Cr (down 5.91% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹105.81 Cr | ₹112.45 Cr | ₹108.74 Cr | ₹92.44 Cr | ₹97.55 Cr | ₹85.97 Cr |
| Other Income | ₹15.76 Cr | ₹23.35 Cr | ₹14.89 Cr | ₹9.93 Cr | ₹4.4 Cr | ₹2.91 Cr |
| Total Income | ₹121.57 Cr | ₹135.8 Cr | ₹123.63 Cr | ₹102.37 Cr | ₹101.95 Cr | ₹88.88 Cr |
| Cost of Materials Consumed | ₹63.25 Cr | ₹70.72 Cr | ₹62.88 Cr | ₹54.67 Cr | ₹54.23 Cr | ₹49.48 Cr |
| Purchases of Stock-in-Trade | ₹16.4 Lakh | ₹93.11 Lakh | ₹5.8 Cr | ₹1.22 Cr | ₹6.4 Cr | ₹1.94 Cr |
| Changes in Inventories | ₹2.94 Cr | -₹1.45 Cr | -₹64.12 Lakh | ₹1.27 Cr | -₹1.15 Cr | -₹42.41 Lakh |
| Employee Benefit Expense | ₹15.81 Cr | ₹14.39 Cr | ₹13.29 Cr | ₹12.17 Cr | ₹11.75 Cr | ₹11.82 Cr |
| Finance Costs | ₹25.8 Lakh | ₹23.18 Lakh | ₹35.92 Lakh | ₹22.34 Lakh | ₹7.79 Lakh | ₹19.62 Lakh |
| Depreciation & Amortisation | ₹2.09 Cr | ₹2.2 Cr | ₹1.95 Cr | ₹1.33 Cr | ₹1.23 Cr | ₹3.16 Cr |
| Other Expenses | ₹20.35 Cr | ₹23.12 Cr | ₹19.31 Cr | ₹15.55 Cr | ₹18.65 Cr | ₹19.79 Cr |
| Total Expenses | ₹104.87 Cr | ₹110.13 Cr | ₹102.95 Cr | ₹86.43 Cr | ₹91.17 Cr | ₹85.97 Cr |
| Profit Before Exceptional Items & Tax | ₹16.7 Cr | ₹25.67 Cr | ₹20.68 Cr | ₹15.94 Cr | ₹10.78 Cr | ₹2.91 Cr |
| Exceptional Items | -₹88.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹15.81 Cr | ₹25.67 Cr | ₹20.68 Cr | ₹15.94 Cr | ₹10.78 Cr | ₹2.91 Cr |
| Total Tax Expense | ₹1.69 Cr | ₹6.16 Cr | ₹3.91 Cr | ₹3.31 Cr | ₹3.54 Cr | ₹1.05 Cr |
| Net Profit | ₹14.13 Cr | ₹19.5 Cr | ₹16.78 Cr | ₹12.63 Cr | ₹7.24 Cr | ₹1.85 Cr |
| attributable to Owners | - | ₹0 | - | ₹0 | ₹0 | - |
| attributable to NCI | - | ₹0 | - | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹0 | ₹14.96 Lakh | ₹8.16 Lakh | -₹20.98 Lakh | ₹2.17 Lakh | ₹2.49 Lakh |
| Total Comprehensive Income | ₹14.13 Cr | ₹19.65 Cr | ₹16.86 Cr | ₹12.42 Cr | ₹7.27 Cr | ₹1.88 Cr |
| EBITDA (computed) | ₹19.05 Cr | ₹28.1 Cr | ₹23 Cr | ₹17.49 Cr | ₹12.09 Cr | ₹6.27 Cr |
| Basic EPS | ₹6.71 | ₹9.34 | ₹8.01 | ₹5.90 | ₹3.45 | ₹0.89 |
| Diluted EPS | ₹0.00 | ₹9.34 | ₹8.01 | ₹5.90 | ₹3.45 | ₹0.89 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹242.14 Cr | ₹222.59 Cr | ₹182.62 Cr | ₹167.45 Cr |
| Non-current Assets | ₹31.25 Cr | ₹31.41 Cr | ₹21.39 Cr | ₹15.36 Cr |
| Current Assets | ₹210.9 Cr | ₹191.18 Cr | ₹161.23 Cr | ₹152.1 Cr |
| Property, Plant & Equipment | ₹20.12 Cr | ₹20.6 Cr | ₹11.41 Cr | ₹6.96 Cr |
| Inventories | ₹13.33 Cr | ₹17.64 Cr | ₹13.67 Cr | ₹12.64 Cr |
| Trade Receivables | ₹40.83 Cr | ₹46.83 Cr | ₹41.4 Cr | ₹46.73 Cr |
| Cash & Equivalents | ₹63.72 Lakh | ₹2.65 Lakh | ₹6.03 Lakh | ₹8.81 Cr |
| Equity (Net Worth) | ₹186.28 Cr | ₹171.43 Cr | ₹151.91 Cr | ₹134.58 Cr |
| Equity Share Capital | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹2.3 Cr |
| Borrowings (Current) | ₹2.51 Cr | ₹0 | ₹5.25 Cr | ₹0 |
| Total Debt (computed) | ₹2.51 Cr | ₹0 | ₹5.25 Cr | ₹2.3 Cr |
| Current Liabilities | ₹52.53 Cr | ₹46.67 Cr | ₹28.32 Cr | ₹30.57 Cr |
| Total Liabilities | ₹55.86 Cr | ₹51.16 Cr | ₹30.71 Cr | ₹32.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹10.66 Cr | ₹7.06 Cr | ₹3.65 Cr | -₹4.85 Cr |
| Investing Cash Flow | -₹12.27 Cr | -₹1.1 Cr | -₹13.34 Cr | ₹1.17 Cr |
| Financing Cash Flow | ₹2.22 Cr | -₹5.48 Cr | ₹2.58 Cr | -₹3.48 Cr |
| Capital Expenditure | ₹3.95 Cr | ₹11.38 Cr | ₹6.39 Cr | ₹1.13 Cr |
| Free Cash Flow (computed) | ₹6.71 Cr | -₹4.32 Cr | -₹2.74 Cr | -₹5.97 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹61.65 Lakh | ₹47.78 Lakh | -₹7.1 Cr | -₹7.15 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹31.4 Cr | ₹29.05 Cr | ₹26.26 Cr | ₹19.11 Cr | ₹39.92 Cr | ₹26.15 Cr | ₹24.94 Cr | ₹21.44 Cr | ₹23.61 Cr | ₹27.31 Cr | ₹32.39 Cr | ₹25.43 Cr |
| Other Income | -₹15.86 Lakh | ₹91.1 Lakh | ₹3.06 Cr | ₹11.94 Cr | ₹2.48 Cr | ₹8.8 Cr | ₹6.91 Cr | ₹5.16 Cr | ₹3.97 Cr | ₹3.53 Cr | ₹2.95 Cr | ₹4.44 Cr |
| Total Income | ₹31.24 Cr | ₹29.96 Cr | ₹29.32 Cr | ₹31.06 Cr | ₹42.4 Cr | ₹34.95 Cr | ₹31.85 Cr | ₹26.6 Cr | ₹27.57 Cr | ₹30.84 Cr | ₹35.35 Cr | ₹29.87 Cr |
| Cost of Materials Consumed | ₹16.6 Cr | ₹18.09 Cr | ₹16.62 Cr | ₹11.94 Cr | ₹31.66 Cr | ₹12.74 Cr | ₹12.1 Cr | ₹14.22 Cr | ₹9.29 Cr | ₹15.42 Cr | ₹21.01 Cr | ₹17.16 Cr |
| Purchases of Stock-in-Trade | ₹13.18 Lakh | ₹2.07 Lakh | ₹1.16 Lakh | ₹0 | ₹2.39 Lakh | ₹48.42 Lakh | ₹23.18 Lakh | ₹19.12 Lakh | ₹2.33 Cr | ₹79.5 Lakh | ₹1.5 Cr | ₹1.17 Cr |
| Changes in Inventories | -₹64.93 Lakh | ₹1.28 Cr | ₹3.26 Cr | -₹95.16 Lakh | -₹4.02 Cr | ₹1.28 Cr | ₹1.95 Cr | -₹66.71 Lakh | -₹1.08 Cr | ₹25.85 Lakh | -₹1.79 Cr | ₹1.97 Cr |
| Employee Benefit Expense | ₹5.04 Cr | ₹3.72 Cr | ₹3.62 Cr | ₹3.43 Cr | ₹4.33 Cr | ₹3.36 Cr | ₹3.38 Cr | ₹3.32 Cr | ₹3.87 Cr | ₹3.2 Cr | ₹3.25 Cr | ₹2.97 Cr |
| Finance Costs | ₹14.87 Lakh | ₹2.74 Lakh | ₹3.43 Lakh | ₹4.75 Lakh | ₹1.57 Lakh | ₹9.03 Lakh | ₹5.08 Lakh | ₹5.17 Lakh | ₹29.44 Lakh | ₹2.41 Lakh | ₹2.37 Lakh | ₹1.7 Lakh |
| Depreciation & Amortisation | ₹22.05 Lakh | ₹64.65 Lakh | ₹67.15 Lakh | ₹55.33 Lakh | ₹58.13 Lakh | ₹55.06 Lakh | ₹52.78 Lakh | ₹54.28 Lakh | ₹52.47 Lakh | ₹66.18 Lakh | ₹49.29 Lakh | ₹27.55 Lakh |
| Other Expenses | ₹6.67 Cr | ₹4.42 Cr | ₹4.99 Cr | ₹4.27 Cr | ₹7.73 Cr | ₹7.54 Cr | ₹3.95 Cr | ₹3.85 Cr | ₹5.68 Cr | ₹5.21 Cr | ₹5.07 Cr | ₹3.3 Cr |
| Total Expenses | ₹28.17 Cr | ₹28.21 Cr | ₹29.2 Cr | ₹19.29 Cr | ₹40.32 Cr | ₹26.05 Cr | ₹22.2 Cr | ₹21.51 Cr | ₹20.92 Cr | ₹25.56 Cr | ₹29.56 Cr | ₹26.86 Cr |
| Profit Before Exceptional Items & Tax | ₹3.07 Cr | ₹1.75 Cr | ₹11.24 Lakh | ₹11.77 Cr | ₹2.08 Cr | ₹8.9 Cr | ₹9.65 Cr | ₹5.1 Cr | ₹6.65 Cr | ₹5.28 Cr | ₹5.79 Cr | ₹3 Cr |
| Exceptional Items | -₹88.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.78 Lakh | ₹1.78 Lakh | ₹0 | ₹2.84 Lakh |
| Profit Before Tax | ₹2.19 Cr | ₹1.75 Cr | ₹11.24 Lakh | ₹11.77 Cr | ₹2.08 Cr | ₹8.9 Cr | ₹9.65 Cr | ₹5.1 Cr | ₹6.67 Cr | ₹5.3 Cr | ₹5.79 Cr | ₹3.03 Cr |
| Total Tax Expense | ₹1.69 Cr | -₹15.59 Lakh | ₹0 | ₹0 | ₹4.2 Cr | ₹20,000 | ₹1.96 Cr | ₹0 | ₹3.12 Cr | ₹78.74 Lakh | ₹0 | ₹0 |
| Net Profit | ₹49.87 Lakh | ₹1.9 Cr | ₹11.24 Lakh | ₹11.77 Cr | -₹2.12 Cr | ₹8.9 Cr | ₹7.69 Cr | ₹5.1 Cr | ₹3.55 Cr | ₹4.51 Cr | ₹5.79 Cr | ₹3.03 Cr |
| attributable to Owners | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| attributable to NCI | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹13.06 Lakh | -₹18,000 | ₹42,000 | -₹26,000 | ₹3.58 Lakh | ₹5.72 Lakh | ₹4.58 Lakh | ₹0 |
| Total Comprehensive Income | ₹49.87 Lakh | ₹1.9 Cr | ₹11.24 Lakh | ₹11.77 Cr | -₹1.99 Cr | ₹8.9 Cr | ₹7.69 Cr | ₹5.09 Cr | ₹3.59 Cr | ₹4.57 Cr | ₹5.84 Cr | ₹3.03 Cr |
| EBITDA (computed) | ₹3.44 Cr | ₹2.42 Cr | ₹81.82 Lakh | ₹12.37 Cr | ₹2.67 Cr | ₹9.54 Cr | ₹10.23 Cr | ₹5.69 Cr | ₹7.47 Cr | ₹5.96 Cr | ₹6.31 Cr | ₹3.3 Cr |
| Basic EPS | ₹0.24 | ₹0.90 | ₹0.05 | ₹5.59 | ₹-0.95 | ₹4.23 | ₹3.66 | ₹2.42 | ₹1.71 | ₹2.17 | ₹2.75 | ₹1.44 |
| Diluted EPS | ₹0.00 | ₹0.90 | ₹0.05 | ₹5.59 | ₹-0.95 | ₹4.23 | ₹3.66 | ₹2.42 | ₹1.71 | ₹2.17 | ₹2.75 | ₹1.44 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹105.81 Cr | ₹111.64 Cr | ₹108.74 Cr | ₹92.44 Cr | ₹97.55 Cr | ₹85.97 Cr |
| Other Income | ₹15.72 Cr | ₹24.11 Cr | ₹14.87 Cr | ₹9.93 Cr | ₹4.41 Cr | ₹2.97 Cr |
| Total Income | ₹121.53 Cr | ₹135.76 Cr | ₹123.61 Cr | ₹102.36 Cr | ₹101.96 Cr | ₹88.94 Cr |
| Cost of Materials Consumed | ₹63.25 Cr | ₹70.72 Cr | ₹62.88 Cr | ₹54.67 Cr | ₹54.23 Cr | ₹49.48 Cr |
| Purchases of Stock-in-Trade | ₹16.41 Lakh | ₹93.11 Lakh | ₹5.8 Cr | ₹1.22 Cr | ₹6.39 Cr | ₹1.94 Cr |
| Changes in Inventories | ₹2.94 Cr | -₹1.45 Cr | -₹64.12 Lakh | ₹1.27 Cr | -₹1.15 Cr | -₹42.41 Lakh |
| Employee Benefit Expense | ₹15.8 Cr | ₹14.37 Cr | ₹13.26 Cr | ₹12.17 Cr | ₹11.75 Cr | ₹11.82 Cr |
| Finance Costs | ₹29.22 Lakh | ₹26.63 Lakh | ₹38.93 Lakh | ₹22.34 Lakh | ₹9.82 Lakh | ₹19.94 Lakh |
| Depreciation & Amortisation | ₹2.09 Cr | ₹2.2 Cr | ₹1.95 Cr | ₹1.33 Cr | ₹1.23 Cr | ₹1.14 Cr |
| Other Expenses | ₹20.35 Cr | ₹22.88 Cr | ₹19.3 Cr | ₹15.54 Cr | ₹18.63 Cr | ₹19.7 Cr |
| Total Expenses | ₹104.89 Cr | ₹109.92 Cr | ₹102.94 Cr | ₹86.43 Cr | ₹91.17 Cr | ₹83.86 Cr |
| Profit Before Exceptional Items & Tax | ₹16.64 Cr | ₹25.84 Cr | ₹20.67 Cr | ₹15.93 Cr | ₹10.79 Cr | ₹5.08 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹16.64 Cr | ₹25.84 Cr | ₹20.67 Cr | ₹15.93 Cr | ₹10.79 Cr | ₹5.08 Cr |
| Total Tax Expense | ₹1.69 Cr | ₹6.16 Cr | ₹3.9 Cr | ₹3.31 Cr | ₹3.53 Cr | ₹99.92 Lakh |
| Net Profit | ₹14.95 Cr | ₹19.68 Cr | ₹16.78 Cr | ₹12.63 Cr | ₹7.26 Cr | ₹4.08 Cr |
| Other Comprehensive Income | -₹88.4 Lakh | ₹14.96 Lakh | ₹8.16 Lakh | -₹20.98 Lakh | ₹2.17 Lakh | ₹2.49 Lakh |
| Total Comprehensive Income | ₹14.07 Cr | ₹19.83 Cr | ₹16.86 Cr | ₹12.42 Cr | ₹7.29 Cr | ₹4.1 Cr |
| EBITDA (computed) | ₹19.02 Cr | ₹28.31 Cr | ₹23.02 Cr | ₹17.48 Cr | ₹12.12 Cr | ₹6.42 Cr |
| Basic EPS | ₹6.69 | ₹9.42 | ₹8.01 | ₹5.90 | ₹3.46 | ₹1.95 |
| Diluted EPS | ₹0.00 | ₹9.42 | ₹8.01 | ₹5.90 | ₹3.46 | ₹1.95 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹251.38 Cr | ₹232.95 Cr | ₹192.67 Cr | ₹177.69 Cr |
| Non-current Assets | ₹42.62 Cr | ₹42.8 Cr | ₹32.65 Cr | ₹26.5 Cr |
| Current Assets | ₹208.75 Cr | ₹190.15 Cr | ₹160.02 Cr | ₹151.18 Cr |
| Property, Plant & Equipment | ₹20.12 Cr | ₹20.6 Cr | ₹11.41 Cr | ₹6.96 Cr |
| Inventories | ₹13.33 Cr | ₹17.64 Cr | ₹13.67 Cr | ₹12.64 Cr |
| Trade Receivables | ₹40.83 Cr | ₹46.83 Cr | ₹41.4 Cr | ₹46.73 Cr |
| Cash & Equivalents | ₹1.21 Cr | ₹2.59 Lakh | ₹4.81 Lakh | ₹8.79 Cr |
| Equity (Net Worth) | ₹196.58 Cr | ₹181.8 Cr | ₹161.97 Cr | ₹144.53 Cr |
| Equity Share Capital | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹2.3 Cr |
| Borrowings (Current) | ₹1.51 Cr | ₹0 | ₹5.25 Cr | ₹29 Lakh |
| Total Debt (computed) | ₹1.51 Cr | ₹0 | ₹5.25 Cr | ₹2.59 Cr |
| Current Liabilities | ₹51.46 Cr | ₹46.65 Cr | ₹28.31 Cr | ₹30.85 Cr |
| Total Liabilities | ₹54.8 Cr | ₹51.15 Cr | ₹30.7 Cr | ₹33.16 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹11.48 Cr | ₹18.39 Cr | ₹3.7 Cr | -₹4.85 Cr |
| Investing Cash Flow | -₹11.58 Cr | -₹12.49 Cr | -₹13.45 Cr | ₹1.17 Cr |
| Financing Cash Flow | -₹1.16 Cr | -₹5.51 Cr | ₹2.26 Cr | -₹3.48 Cr |
| Capital Expenditure | ₹3.95 Cr | ₹11.38 Cr | ₹6.39 Cr | ₹1.13 Cr |
| Free Cash Flow (computed) | ₹7.53 Cr | ₹7.01 Cr | -₹2.69 Cr | -₹5.98 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.26 Cr | ₹39.15 Lakh | -₹7.49 Cr | -₹7.16 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹31.4 Cr | ₹29.67 Cr | ₹25.63 Cr | ₹19.11 Cr | ₹39.11 Cr | ₹26.15 Cr | ₹24.94 Cr | ₹21.44 Cr | ₹23.61 Cr | ₹27.31 Cr | ₹32.39 Cr | ₹25.43 Cr |
| Other Income | -₹18.28 Lakh | ₹26.05 Lakh | ₹3.69 Cr | ₹11.96 Cr | ₹3.24 Cr | ₹8.8 Cr | ₹6.91 Cr | ₹5.16 Cr | ₹3.95 Cr | ₹3.53 Cr | ₹2.95 Cr | ₹4.44 Cr |
| Total Income | ₹31.21 Cr | ₹29.93 Cr | ₹29.32 Cr | ₹31.07 Cr | ₹42.35 Cr | ₹34.95 Cr | ₹31.85 Cr | ₹26.6 Cr | ₹27.56 Cr | ₹30.84 Cr | ₹35.35 Cr | ₹29.87 Cr |
| Cost of Materials Consumed | ₹16.6 Cr | ₹18.16 Cr | ₹16.55 Cr | ₹11.94 Cr | ₹31.66 Cr | ₹12.74 Cr | ₹12.1 Cr | ₹14.22 Cr | ₹9.29 Cr | ₹15.42 Cr | ₹21.01 Cr | ₹17.16 Cr |
| Purchases of Stock-in-Trade | ₹13.18 Lakh | ₹2.07 Lakh | ₹1.16 Lakh | ₹0 | ₹2.39 Lakh | ₹48.42 Lakh | ₹23.18 Lakh | ₹19.12 Lakh | ₹2.33 Cr | ₹79.5 Lakh | ₹1.5 Cr | ₹1.17 Cr |
| Changes in Inventories | -₹64.94 Lakh | ₹1.28 Cr | ₹3.26 Cr | -₹95.16 Lakh | -₹4.02 Cr | ₹1.28 Cr | ₹1.95 Cr | -₹66.71 Lakh | -₹1.08 Cr | ₹25.85 Lakh | -₹1.79 Cr | ₹1.97 Cr |
| Employee Benefit Expense | ₹5.03 Cr | ₹3.72 Cr | ₹3.62 Cr | ₹3.43 Cr | ₹4.31 Cr | ₹3.36 Cr | ₹3.38 Cr | ₹3.31 Cr | ₹3.87 Cr | ₹3.17 Cr | ₹3.25 Cr | ₹2.97 Cr |
| Finance Costs | ₹16.21 Lakh | ₹3.14 Lakh | ₹4.61 Lakh | ₹5.26 Lakh | ₹5.02 Lakh | ₹10.11 Lakh | ₹6.16 Lakh | ₹5.34 Lakh | ₹30.39 Lakh | ₹3.2 Lakh | ₹3.64 Lakh | ₹1.7 Lakh |
| Depreciation & Amortisation | ₹22.05 Lakh | ₹64.65 Lakh | ₹67.15 Lakh | ₹55.33 Lakh | ₹58.13 Lakh | ₹55.06 Lakh | ₹52.78 Lakh | ₹54.28 Lakh | ₹52.47 Lakh | ₹66.18 Lakh | ₹49.29 Lakh | ₹27.55 Lakh |
| Other Expenses | ₹6.67 Cr | ₹4.35 Cr | ₹5.06 Cr | ₹4.27 Cr | ₹7.5 Cr | ₹7.54 Cr | ₹4 Cr | ₹3.85 Cr | ₹5.68 Cr | ₹5.2 Cr | ₹5.11 Cr | ₹3.31 Cr |
| Total Expenses | ₹28.17 Cr | ₹28.21 Cr | ₹29.22 Cr | ₹19.29 Cr | ₹40.1 Cr | ₹26.06 Cr | ₹22.26 Cr | ₹21.5 Cr | ₹20.92 Cr | ₹25.54 Cr | ₹29.61 Cr | ₹26.87 Cr |
| Profit Before Exceptional Items & Tax | ₹3.04 Cr | ₹1.72 Cr | ₹10.12 Lakh | ₹11.78 Cr | ₹2.25 Cr | ₹8.89 Cr | ₹9.59 Cr | ₹5.11 Cr | ₹6.64 Cr | ₹5.3 Cr | ₹5.74 Cr | ₹3 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.82 Lakh | ₹1.78 Lakh | ₹1.78 Lakh | ₹0 | ₹2.84 Lakh |
| Profit Before Tax | ₹3.04 Cr | ₹1.72 Cr | ₹10.12 Lakh | ₹11.78 Cr | ₹2.25 Cr | ₹8.89 Cr | ₹9.59 Cr | ₹5.12 Cr | ₹6.66 Cr | ₹5.32 Cr | ₹5.74 Cr | ₹3.03 Cr |
| Total Tax Expense | ₹1.69 Cr | -₹15.59 Lakh | ₹0 | ₹0 | ₹4.2 Cr | ₹0 | ₹1.96 Cr | ₹0 | ₹3.11 Cr | ₹78.74 Lakh | ₹0 | ₹0 |
| Net Profit | ₹1.36 Cr | ₹1.87 Cr | ₹10.12 Lakh | ₹11.78 Cr | -₹1.95 Cr | ₹8.89 Cr | ₹7.63 Cr | ₹5.12 Cr | ₹3.55 Cr | ₹4.53 Cr | ₹5.74 Cr | ₹3.03 Cr |
| Other Comprehensive Income | -₹88.4 Lakh | ₹0 | ₹0 | ₹0 | ₹13.06 Lakh | ₹1.9 Lakh | ₹0 | ₹0 | ₹3.58 Lakh | ₹0 | ₹4.58 Lakh | ₹0 |
| Total Comprehensive Income | ₹47.3 Lakh | ₹1.87 Cr | ₹10.12 Lakh | ₹11.78 Cr | -₹1.82 Cr | ₹8.91 Cr | ₹7.63 Cr | ₹5.12 Cr | ₹3.58 Cr | ₹4.53 Cr | ₹5.78 Cr | ₹3.03 Cr |
| EBITDA (computed) | ₹3.43 Cr | ₹2.4 Cr | ₹81.88 Lakh | ₹12.38 Cr | ₹2.88 Cr | ₹9.54 Cr | ₹10.18 Cr | ₹5.7 Cr | ₹7.47 Cr | ₹5.99 Cr | ₹6.27 Cr | ₹3.29 Cr |
| Basic EPS | ₹0.64 | ₹0.89 | ₹0.05 | ₹5.60 | ₹-0.86 | ₹4.24 | ₹3.63 | ₹2.44 | ₹1.70 | ₹2.15 | ₹2.75 | ₹1.44 |
| Diluted EPS | ₹0.00 | ₹0.89 | ₹0.05 | ₹5.60 | ₹-0.86 | ₹4.24 | ₹3.63 | ₹2.44 | ₹1.70 | ₹2.15 | ₹2.75 | ₹1.44 |
Board & Governance of Alpa Laboratories Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Alpa Laboratories Limited has 10 directors - 5 independent and 5 executive. The board is chaired by MAHENDRA SINGH CHAWLA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| MAHENDRA SINGH CHAWLA | Executive Director · Chairperson | 1988-03-18 | 1 |
| PARESH CHAWLA | Executive Director · MD | 2016-05-28 | 1 |
| PRAVIN CHANDRA SHAH | Executive Director | 2009-03-01 | 1 |
| JYOTI JAIN | Non-Executive - Independent Director | 2016-07-20 | 1 |
| VITTHAL KOTHANA | Executive Director | 2022-08-13 | 1 |
| SHITUL SHAH | Executive Director | 2023-08-14 | 1 |
| PRATIBHA LUNAWAT | Non-Executive - Independent Director | 2023-08-28 | 1 |
| SANKET BAHETI | Non-Executive - Independent Director | 2023-08-28 | 1 |
| SUNIL KUMAR VALECHA | Non-Executive - Independent Director | 2023-08-28 | 1 |
| PRATIK SHAH | Non-Executive - Independent Director | 2024-08-31 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | SUNIL KUMAR VALECHA (Chairperson), MAHENDRA SINGH CHAWLA, PRATIBHA LUNAWAT |
| Nomination and remuneration committee | SANKET BAHETI (Chairperson), JYOTI JAIN, SUNIL KUMAR VALECHA |
| Stakeholders Relationship Committee | SUNIL KUMAR VALECHA (Chairperson), MAHENDRA SINGH CHAWLA, JYOTI JAIN |
| Corporate Social Responsibility Committee | PRAVIN CHANDRA SHAH (Chairperson), SUNIL KUMAR VALECHA, PRATIBHA LUNAWAT |
Charges & Borrowings of Alpa Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2025 | Hdfc Bank Limited | ₹7 Cr | Open |
| 06 Jan 2024 | Hdfc Bank Limited | ₹5 Cr | Open |
| 06 Dec 2017 | Others | ₹14 Cr | Open |
| 24 Apr 2019 | Yes Bank Limited | ₹10 Cr | Satisfied |
| 01 Sep 2017 | Hdfc Bank Limited | ₹37 Lakh | Satisfied |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Alpa Laboratories Limited
View historical data on people associated with Alpa Laboratories Limited, including employment history and EPFO contributions.
Employee and EPFO history for Alpa Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Alpa Laboratories Limited
GST registrations and filing compliance for Alpa Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Alpa Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Alpa Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Alpa Laboratories Limited
MSME payment history for Alpa Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Alpa Laboratories Limited
Corporate group structure for Alpa Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Alpa Laboratories Limited
MCA filings and documents for Alpa Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Alpa Laboratories Limited
Recent News on Alpa Laboratories Limited
Frequently Asked Questions about Alpa Laboratories Limited
Alpa Laboratories Limited is an active public limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 18 March 1988 (38+ years old) and is registered under CIN L85195MP1988PLC004446. Listed on BSE: 532878 and NSE: BE : ALPA. The company has 367 employees.
Alpa Laboratories Limited reported revenue of ₹105.81 Cr for FY 2026 (down 5.91% YoY) based on consolidated NSE filings.
The current directors and KMP of Alpa Laboratories Limited are:
- Bakulesh Shah - Cfo
- Mahendra Singh Chawla - Whole-Time Director
- Pravin Chandra Shah - Whole-Time Director
- Paresh Chawla - Managing Director
- Jyoti Jain - Director
- Vitthal Kothana - Director
- Pratik Shah - Director
- Shitul Shah - Whole-Time Director
- Sanket Baheti - Director
- Sunil Kumar Valecha - Director
- Pratibha Lunawat - Director
The primary industry of Alpa Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Alpa Laboratories Limited is listed on both BSE (code: 532878) and NSE (symbol: BE : ALPA).
Alpa Laboratories Limited can be reached at the registered office: 332 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446, or through the website alpalabs.in.